|
Market Closed -
Other stock markets
|
Pre-market 06:16:30 | |||
| 23.95 EUR | +1.91% |
|
23.92 | -0.10% |
| 02-11 | Formycon, Lotus Sign License Deal for Keytruda Biosimilar in Asia-Pacific Region | MT |
| 02-11 | Swiss stocks - Factors to watch on February 11 | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- FYB Stock
- Consensus Formycon AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition